PDL BioPharma Inc (NASDAQ:PDLI)

2.86
Delayed Data
As of 3:50pm ET
 +0.10 / +3.62%
Today’s Change
2.15
Today|||52-Week Range
3.55
+4.38%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.76
Today’s open2.76
Day’s range2.76 - 2.88
Volume1,803,212
Average volume (3 months)1,495,307
Market cap$420.3M
Data as of 3:50pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)+82.05%
Earnings growth (this year)-76.06%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+33.54%
P/E ratio4.2
Price/Sales1.34
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc-0.06-1.54%
ATRAAtara Biotherapeutic...-1.05-2.04%
CYADCelyad SA+0.60+2.11%
BCRXBioCryst Pharmaceuti...+0.08+1.47%
Data as of 3:50pm ET, 05/22/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)$0.06
Annual revenue (last year)$320.1M
Annual profit (last year)$110.7M
Net profit margin34.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts